Daniel Menold - Net Worth and Insider Trading

Daniel Menold Net Worth

The estimated net worth of Daniel Menold is at least $0 dollars as of 2024-11-05. Daniel Menold is the Vice President, Finance of CymaBay Therapeutics Inc and owns about 0 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $0. Details can be seen in Daniel Menold's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Menold has not made any transactions after 2024-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Daniel Menold

To

Daniel Menold Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Menold owns 1 companies in total, including CymaBay Therapeutics Inc (CBAY) .

Click here to see the complete history of Daniel Menold’s form 4 insider trades.

Insider Ownership Summary of Daniel Menold

Ticker Comapny Transaction Date Type of Owner
CBAY CymaBay Therapeutics Inc 2024-01-16 Vice President & Finance

Daniel Menold Latest Holdings Summary

Daniel Menold currently owns a total of 1 stock. Daniel Menold owns 0 shares of CymaBay Therapeutics Inc (CBAY) as of January 16, 2024, with a value of $0.

Latest Holdings of Daniel Menold

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CBAY CymaBay Therapeutics Inc 2024-01-16 0 32.48 0

Holding Weightings of Daniel Menold


Daniel Menold Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Menold has made a total of 3 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in CymaBay Therapeutics Inc is the sale of 10,000 shares on January 16, 2024, which brought Daniel Menold around $235,800.

Insider Trading History of Daniel Menold

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Menold Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel Menold Ownership Network

Ownership Network List of Daniel Menold

No Data

Ownership Network Relation of Daniel Menold

Insider Network Chart

Daniel Menold Owned Company Details

What does CymaBay Therapeutics Inc do?

Who are the key executives at CymaBay Therapeutics Inc?

Daniel Menold is the Vice President & Finance of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Chief Scientific Officer Charles Mcwherter , General Counsel Paul T Quinlan , and director & Chief Executive Officer Sujal Shah .

CymaBay Therapeutics Inc (CBAY) Insider Trades Summary

Over the past 18 months, Daniel Menold made 3 insider transaction in CymaBay Therapeutics Inc (CBAY) with a net sale of 52,442. Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 171,559 shares made by Charles Mcwherter , a net sale of 93,000 shares made by Paul T Quinlan , and a net sale of 19,000 shares made by Janet Dorling .

In summary, during the past 3 months, insiders sold 0 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 481,646 shares of CymaBay Therapeutics Inc (CBAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 481,646 shares.

CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CymaBay Therapeutics Inc Insider Transactions

No Available Data

Daniel Menold Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Menold. You might contact Daniel Menold via mailing address: C/o Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark Ca 94560.